Novavax to Present at the 14th Annual Needham Healthcare Conference
GAITHERSBURG, Md., April 8, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced Stanley C. Erck, President and Chief Executive Officer, will present at the 14th Annual Needham Healthcare Conference at 8:00 a.m. ET, April 15, 2015 in New York City at the Westin Grand Central Hotel.
A live webcast link for the presentation will be available via the company website at www.novavax.com under Investor Info/Events.
NVAX